search
Back to results

Treatment of Iron Deficiency Anemia in Malaria Endemic Ghana

Primary Purpose

Anemia

Status
Completed
Phase
Not Applicable
Locations
Ghana
Study Type
Interventional
Intervention
Sprinkles®
vitamin/mineral fortificant without iron
Sponsored by
The Hospital for Sick Children
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Anemia focused on measuring Iron deficiency anemia, Sprinkles®, micronutrients, malaria incidence, iron supplement

Eligibility Criteria

6 Months - 24 Months (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Age 6-24 months
  • Ingesting weaning food in addition to breastmilk
  • Free from malaria or other major illnesses
  • Afebrile
  • Living in Brong Ahafo Region of Ghana for duration of intervention and follow-up

Exclusion Criteria:

  • Severe anemia (hemoglobin <70g/L)
  • Weight-for-height <-3 z-score(severe wasting)
  • Kwashiorkor (defined as evidence of edema)
  • Congenital abnormality
  • Treatment with iron supplements within the past 6 months
  • Presence of any chronic illness

Sites / Locations

  • Kintampo Health Research Centre

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Vitamin/mineral fortificant with iron

Vitamin/mineral fortificant without iron

Arm Description

Outcomes

Primary Outcome Measures

incidence of clinical malaria (if fever recorded a blood sample will be taken to determine parasite species and count)

Secondary Outcome Measures

changes in anemia status (blood levels of: haemoglobin(Hb) , ferritin (SF))
severity of clinical malaria (blood parasite count)
cerebral malaria (defined by a parasite count >5000/μL blood and a concurrent score of <2 on the Blantyre coma scale, with or without convulsions)
hospitalization (documentation of hospitalization for any reason)
death
pneumonia (defined by the presence of a cough or breathing difficulties, tachypnea, lower chest wall indrawing, and the appearance of consolidation or pleural effusion on a chest X-ray)
diarrhea (defined by >3 loose or watery stools in the previous 24 hours)
dehydration (defined by lethargy, sunken eyes, and decreased skin turgor [>2 seconds for skin to return following a skin pinch])

Full Information

First Posted
October 21, 2009
Last Updated
April 14, 2021
Sponsor
The Hospital for Sick Children
search

1. Study Identification

Unique Protocol Identification Number
NCT01001871
Brief Title
Treatment of Iron Deficiency Anemia in Malaria Endemic Ghana
Official Title
Seasonal Impact of Iron Fortification on Malaria Incidence in Ghanaian Children
Study Type
Interventional

2. Study Status

Record Verification Date
April 2021
Overall Recruitment Status
Completed
Study Start Date
November 2009 (Actual)
Primary Completion Date
October 2010 (Actual)
Study Completion Date
May 2011 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Hospital for Sick Children

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Iron deficiency and iron deficiency anemia (IDA) are the most prevalent micronutrient deficiencies on a worldwide basis, especially in developing countries. The impact of severe IDA can have mortal consequences, since without adequate hemoglobin, the brain and body become deprived of oxygen and, if allowed to continue, death may ensue. It has been shown that iron supplementation in infants and young children can enhance child development, however, it may also result in increased rates of malaria in high burden areas. The primary objective of this study is to determine the impact of providing encapsulated iron (as a powder added to complementary foods) on the susceptibility to clinical malaria among anemic and non-anemic infants and young children (6-24 months of age) living in a high malaria burden area. The value of performing this research in Ghana is primarily that malaria and anemia remain the most important causes of death and morbidity.
Detailed Description
Study Design: The proposed study is a community-based blinded randomized controlled trial with 2 study arms that will be conducted in two phases: Phase I will take place during the dry season (December to April), when malaria transmission rates are lower. Eligible subjects (one per household) will be individually randomized to receive a daily dose of either a powdered vitamin/mineral fortificant containing 12.5 mg of iron (plus ascorbic acid, vitamin A and zinc), or a placebo (containing all micronutrients excluding iron), added to complementary foods, for 5 months. Phase II will take place during the wet season (June to October), when malaria transmission rates are higher. Eligible subjects, who did not participate in Phase I, will be individually randomized to one of the two study arms as described above and followed for 5 months. A dual phase design, with two unique cohorts, was chosen so that preliminary results (at the end of phase 1) could be assessed by an independent Data Safety and Monitoring Committee. It is possible that during the dry season no impact of iron will be detected, while during the wet season, an impact will be observed. With this possible outcome, it is potentially feasible to translate this knowledge into a Ministry of Health Program to only provide iron supplementation (fortification) during the dry months of the year (December to April).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anemia
Keywords
Iron deficiency anemia, Sprinkles®, micronutrients, malaria incidence, iron supplement

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
3880 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Vitamin/mineral fortificant with iron
Arm Type
Experimental
Arm Title
Vitamin/mineral fortificant without iron
Arm Type
Placebo Comparator
Intervention Type
Dietary Supplement
Intervention Name(s)
Sprinkles®
Intervention Description
powdered vitamin/mineral fortificant WITH iron sprinkled onto food once a day for 5 months
Intervention Type
Dietary Supplement
Intervention Name(s)
vitamin/mineral fortificant without iron
Intervention Description
powdered vitamin/mineral fortificant WITHOUT iron sprinkled onto food once a day for 5 months
Primary Outcome Measure Information:
Title
incidence of clinical malaria (if fever recorded a blood sample will be taken to determine parasite species and count)
Time Frame
5 months
Secondary Outcome Measure Information:
Title
changes in anemia status (blood levels of: haemoglobin(Hb) , ferritin (SF))
Time Frame
5 months
Title
severity of clinical malaria (blood parasite count)
Time Frame
5 months
Title
cerebral malaria (defined by a parasite count >5000/μL blood and a concurrent score of <2 on the Blantyre coma scale, with or without convulsions)
Time Frame
5 months
Title
hospitalization (documentation of hospitalization for any reason)
Time Frame
5 months
Title
death
Time Frame
5 months
Title
pneumonia (defined by the presence of a cough or breathing difficulties, tachypnea, lower chest wall indrawing, and the appearance of consolidation or pleural effusion on a chest X-ray)
Time Frame
5 months
Title
diarrhea (defined by >3 loose or watery stools in the previous 24 hours)
Time Frame
5 months
Title
dehydration (defined by lethargy, sunken eyes, and decreased skin turgor [>2 seconds for skin to return following a skin pinch])
Time Frame
5 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Months
Maximum Age & Unit of Time
24 Months
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Age 6-24 months Ingesting weaning food in addition to breastmilk Free from malaria or other major illnesses Afebrile Living in Brong Ahafo Region of Ghana for duration of intervention and follow-up Exclusion Criteria: Severe anemia (hemoglobin <70g/L) Weight-for-height <-3 z-score(severe wasting) Kwashiorkor (defined as evidence of edema) Congenital abnormality Treatment with iron supplements within the past 6 months Presence of any chronic illness
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stanley H Zlotkin, PhD
Organizational Affiliation
The Hospital for Sick Children, Toronto, Canada
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kintampo Health Research Centre
City
Kintampo
ZIP/Postal Code
PO Box 200
Country
Ghana

12. IPD Sharing Statement

Citations:
PubMed Identifier
34283841
Citation
Tchum SK, Sakyi SA, Adu B, Arthur F, Oppong FB, Dzabeng F, Amoani B, Gyan T, Poku-Asante K. Impact of IgG response to malaria-specific antigens and immunity against malaria in pre-school children in Ghana. A cluster randomized, placebo-controlled trial. PLoS One. 2021 Jul 20;16(7):e0253544. doi: 10.1371/journal.pone.0253544. eCollection 2021.
Results Reference
derived
PubMed Identifier
28592572
Citation
Aimone AM, Brown P, Owusu-Agyei S, Zlotkin SH, Cole DC. Impact of iron fortification on the geospatial patterns of malaria and non-malaria infection risk among young children: a secondary spatial analysis of clinical trial data from Ghana. BMJ Open. 2017 Jun 6;7(5):e013192. doi: 10.1136/bmjopen-2016-013192.
Results Reference
derived
PubMed Identifier
27391972
Citation
Aimone AM, Brown PE, Zlotkin SH, Cole DC, Owusu-Agyei S. Geo-spatial factors associated with infection risk among young children in rural Ghana: a secondary spatial analysis. Malar J. 2016 Jul 8;15:349. doi: 10.1186/s12936-016-1388-1.
Results Reference
derived
PubMed Identifier
24002280
Citation
Zlotkin S, Newton S, Aimone AM, Azindow I, Amenga-Etego S, Tchum K, Mahama E, Thorpe KE, Owusu-Agyei S. Effect of iron fortification on malaria incidence in infants and young children in Ghana: a randomized trial. JAMA. 2013 Sep 4;310(9):938-47. doi: 10.1001/jama.2013.277129.
Results Reference
derived

Learn more about this trial

Treatment of Iron Deficiency Anemia in Malaria Endemic Ghana

We'll reach out to this number within 24 hrs